Edition:
India

Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

4.37USD
19 Jan 2018
Change (% chg)

$0.05 (+1.16%)
Prev Close
$4.32
Open
$4.36
Day's High
$4.39
Day's Low
$4.33
Volume
2,173
Avg. Vol
18,808
52-wk High
$32.70
52-wk Low
$3.04

Chart for

About

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development... (more)

Overall

Beta: --
Market Cap(Mil.): $301.51
Shares Outstanding(Mil.): 23.59
Dividend: 23.12
Yield (%): --

Financials

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018

30 Nov 2017

BRIEF-Forward Pharma announces completion of corporate restructuring plan

* Forward Pharma announces completion of corporate restructuring plan Source text for Eikon: Further company coverage:

23 Nov 2017

BRIEF-Forward Pharma board approves capital reduction

* Forward Pharma board of directors approves capital reduction and returns EUR 917.7 million to shareholders

01 Sep 2017

BRIEF-Forward Pharma obtains shareholder approval of capital reduction

* Forward Pharma obtains shareholder approval of the planned capital reduction at the extraordinary general meeting

03 Aug 2017

Earnings vs. Estimates